Metabolism  ||| S:0 E:11 ||| NNP
and  ||| S:11 E:15 ||| CC
biological  ||| S:15 E:26 ||| JJ
functions  ||| S:26 E:36 ||| NNS
of  ||| S:36 E:39 ||| IN
human  ||| S:39 E:45 ||| JJ
milk  ||| S:45 E:50 ||| NN
oligosaccharides  ||| S:50 E:67 ||| VBD
It  ||| S:67 E:70 ||| PRP
is  ||| S:70 E:73 ||| VBZ
well  ||| S:73 E:78 ||| RB
known  ||| S:78 E:84 ||| VBN
that  ||| S:84 E:89 ||| IN
breastfeeding  ||| S:89 E:103 ||| NN
is  ||| S:103 E:106 ||| VBZ
beneficial  ||| S:106 E:117 ||| JJ
both  ||| S:117 E:122 ||| CC
for  ||| S:122 E:126 ||| IN
its  ||| S:126 E:130 ||| PRP$
nutritional  ||| S:130 E:142 ||| JJ
properties  ||| S:142 E:153 ||| NNS
and  ||| S:153 E:157 ||| CC
for  ||| S:157 E:161 ||| IN
the  ||| S:161 E:165 ||| DT
presence  ||| S:165 E:174 ||| NN
of  ||| S:174 E:177 ||| IN
biologically  ||| S:177 E:190 ||| JJ
active  ||| S:190 E:197 ||| JJ
compounds ||| S:197 E:206 ||| NN
.  ||| S:206 E:208 ||| .
Among  ||| S:208 E:214 ||| IN
these ||| S:214 E:219 ||| DT
,  ||| S:219 E:221 ||| ,
human  ||| S:221 E:227 ||| JJ
milk  ||| S:227 E:232 ||| NN
oligosaccharides  ||| S:232 E:249 ||| NNS
( ||| S:249 E:250 ||| -LRB-
HMOs ||| S:250 E:254 ||| NNP
) ||| S:254 E:255 ||| -RRB-
,  ||| S:255 E:257 ||| ,
representing  ||| S:257 E:270 ||| VBG
the  ||| S:270 E:274 ||| DT
third  ||| S:274 E:280 ||| JJ
largest  ||| S:280 E:288 ||| JJS
fraction  ||| S:288 E:297 ||| NN
of  ||| S:297 E:300 ||| IN
human  ||| S:300 E:306 ||| JJ
milk ||| S:306 E:310 ||| NN
,  ||| S:310 E:312 ||| ,
have  ||| S:312 E:317 ||| VBP
been  ||| S:317 E:322 ||| VBN
assigned  ||| S:322 E:331 ||| VBN
important  ||| S:331 E:341 ||| JJ
biological  ||| S:341 E:352 ||| JJ
functions ||| S:352 E:361 ||| NNS
,  ||| S:361 E:363 ||| ,
such  ||| S:363 E:368 ||| JJ
as  ||| S:368 E:371 ||| IN
prebiotic  ||| S:371 E:381 ||| NN
and  ||| S:381 E:385 ||| CC
immunomodulatory  ||| S:385 E:402 ||| NNS
and  ||| S:402 E:406 ||| CC
antimicrobial  ||| S:406 E:420 ||| JJ
effects ||| S:420 E:427 ||| NNS
.  ||| S:427 E:429 ||| .
HMOs  ||| S:429 E:434 ||| NNS
are  ||| S:434 E:438 ||| VBP
synthesized  ||| S:438 E:450 ||| VBN
in  ||| S:450 E:453 ||| IN
the  ||| S:453 E:457 ||| DT
mammary  ||| S:457 E:465 ||| JJ
gland  ||| S:465 E:471 ||| NN
by  ||| S:471 E:474 ||| IN
glycosyltransferase  ||| S:474 E:494 ||| JJ
enzymes  ||| S:494 E:502 ||| NN
and  ||| S:502 E:506 ||| CC
can  ||| S:506 E:510 ||| MD
be  ||| S:510 E:513 ||| VB
divided  ||| S:513 E:521 ||| VBN
in  ||| S:521 E:524 ||| IN
core-oligosaccharides ||| S:524 E:545 ||| NNP
,  ||| S:545 E:547 ||| ,
sialo-oligosaccharides ||| S:547 E:569 ||| NNP
,  ||| S:569 E:571 ||| ,
fucosyl-oligosaccharides  ||| S:571 E:596 ||| JJ
and  ||| S:596 E:600 ||| CC
sialo-fucosyl-oligosaccharides  ||| S:600 E:631 ||| JJ
on  ||| S:631 E:634 ||| IN
the  ||| S:634 E:638 ||| DT
basis  ||| S:638 E:644 ||| NN
of  ||| S:644 E:647 ||| IN
their  ||| S:647 E:653 ||| PRP$
chemical  ||| S:653 E:662 ||| NN
structure ||| S:662 E:671 ||| NN
.  ||| S:671 E:673 ||| .
Glycosyltransferases  ||| S:673 E:694 ||| JJ
enzymes  ||| S:694 E:702 ||| NNS
are  ||| S:702 E:706 ||| VBP
partially  ||| S:706 E:716 ||| RB
regulated  ||| S:716 E:726 ||| VBN
by  ||| S:726 E:729 ||| IN
genetic  ||| S:729 E:737 ||| JJ
mechanisms ||| S:737 E:747 ||| NNS
;  ||| S:747 E:749 ||| :
according  ||| S:749 E:759 ||| VBG
to  ||| S:759 E:762 ||| TO
the  ||| S:762 E:766 ||| DT
expression  ||| S:766 E:777 ||| NN
of  ||| S:777 E:780 ||| IN
secretory  ||| S:780 E:790 ||| NN
and  ||| S:790 E:794 ||| CC
Lewis ||| S:794 E:799 ||| NNP
'  ||| S:799 E:801 ||| POS
genes ||| S:801 E:806 ||| NNS
,  ||| S:806 E:808 ||| ,
it  ||| S:808 E:811 ||| PRP
is  ||| S:811 E:814 ||| VBZ
possible  ||| S:814 E:823 ||| JJ
to  ||| S:823 E:826 ||| TO
classify  ||| S:826 E:835 ||| VB
human  ||| S:835 E:841 ||| JJ
milk  ||| S:841 E:846 ||| NN
in  ||| S:846 E:849 ||| IN
4  ||| S:849 E:851 ||| CD
different  ||| S:851 E:861 ||| JJ
secretory  ||| S:861 E:871 ||| JJ
groups ||| S:871 E:877 ||| NNS
.  ||| S:877 E:879 ||| .
We  ||| S:879 E:882 ||| PRP
hereby  ||| S:882 E:889 ||| RB
present  ||| S:889 E:897 ||| VB
a  ||| S:897 E:899 ||| DT
review  ||| S:899 E:906 ||| NN
of  ||| S:906 E:909 ||| IN
the  ||| S:909 E:913 ||| DT
current  ||| S:913 E:921 ||| JJ
knowledge  ||| S:921 E:931 ||| NN
concerning  ||| S:931 E:942 ||| VBG
HMOs ||| S:942 E:946 ||| JJ
,  ||| S:946 E:948 ||| ,
their  ||| S:948 E:954 ||| PRP$
metabolism  ||| S:954 E:965 ||| NN
and  ||| S:965 E:969 ||| CC
main  ||| S:969 E:974 ||| JJ
biological  ||| S:974 E:985 ||| JJ
functions ||| S:985 E:994 ||| NNS
.  ||| S:994 E:996 ||| .
